Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TurkuPET: Sacubitril/Valsartan in Heart Failure
NCT03300427Phase 4Completed
- Sponsor
- Novartis
- Start
- Jul 2018
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sacubitril + valsartan in heart failure (HF), sponsored by Novartis. Started Jul 2018; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03300427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03300427.